BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

NCT00028561 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

45

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: ixabepilone
DRUG: carboplatin
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)